Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan

被引:0
|
作者
Sogawa, Rintaro [1 ]
Hatano, Masakazu [2 ]
Nishimura, Fumi [1 ]
Nishi, Junya [1 ]
Matsuoka, Ayaka [3 ]
Shinada, Kota [3 ]
Yamada, Haruna [4 ]
Tateishi, Hiroshi [5 ]
Mizoguchi, Yoshito [5 ]
Monji, Akira [6 ]
Shimanoe, Chisato [1 ]
机构
[1] Saga Univ Hosp, Dept Pharm, 5-1-1 Nabeshima, Saga 8498501, Japan
[2] Fujita Hlth Univ, Sch Med, Dept Pharmacotherapeut & Informat, Toyoake, Japan
[3] Saga Univ Hosp, Dept Emergency & Crit Care Med, Nabeshima, Japan
[4] Saga Univ, Inst Nursing, Fac Med, Nabeshima, Japan
[5] Saga Univ, Fac Med, Dept Psychiat, Nabeshima, Japan
[6] Wakahisa Hosp, Wakahisa, Japan
来源
IN VIVO | 2025年 / 39卷 / 01期
关键词
Accident; adverse drug event; hypnotics; injury; HIGHWAY DRIVING PERFORMANCE; ZOPICLONE; 7.5; MG; METAANALYSIS; MEDICATION; FALLS; RISK; PLACEBO;
D O I
10.21873/invivo.13846
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: The use of hypnotic drugs can lead to accidents and injuries. However, few reports have shown their association with these events after adjusting for many concomitant medications. This study aimed to determine whether the use of hypnotic drugs was associated with accidents and injuries. Patients and Methods: Using the Japanese Adverse Event Reporting Database, 772,387 reports published between September 2023 and April 2004 were analyzed. Reporting odds ratios (RORs) and 95% confidence intervals (CIs) for accidents and injuries associated with each hypnotic drug were calculated after adjusting for potential confounders. Results: Of the total, 12,484 reports indicated association of hypnotic drugs with accidents and injuries. The use of each hypnotic drug was associated with accidents, injuries, and other adverse events. However, a multivariate analysis adjusted for age, sex, reporting year, and concomitant medications showed a considerable decrease in ROR for melatonin receptor agonists (adjusted ROR=1.26; 95%CI=1.03-1.55) and dual orexin receptor antagonists (DORAs) (adjusted ROR=1.04; 95%CI=0.86-1.25). Particularly in DORAs, a loss of signal for accidents and injuries was observed. Conclusion: The risk of accidents and injuries may vary with hypnotic drug use; however, DORAs may be less frequently associated with these events. The results of this study provide useful information for the selection of hypnotic drugs.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 50 条
  • [1] Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan
    Yukiko Ishibashi
    Rintaro Sogawa
    Kenji Ogata
    Ayaka Matsuoka
    Haruna Yamada
    Toru Murakawa-Hirachi
    Yoshito Mizoguchi
    Akira Monji
    Chisato Shimanoe
    Clinical Drug Investigation, 2024, 44 : 115 - 120
  • [2] Hypnotics and infections: disproportionality analysis of the US Food & Drug Administration adverse event reporting system database
    Meng, Long
    Huang, Jing
    He, Qin
    Zhao, Yibei
    Zhao, Wenlong
    Tan, Juntao
    Sun, Shusen
    Yang, Junqing
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2022, 18 (09): : 2229 - 2235
  • [3] Correction to: Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan (10.1007/s40261-023-01337-9)
    Ishibashi, Yukiko
    Sogawa, Rintaro
    Ogata, Kenji
    Matsuoka, Ayaka
    Yamada, Haruna
    Murakawa-Hirachi, Toru
    Mizoguchi, Yoshito
    Monji, Akira
    Shimanoe, Chisato
    CLINICAL DRUG INVESTIGATION, 2024, 44 (02) : 121 - 121
  • [4] A pharmacovigilance study of the association between proton pump inhibitors and tumor adverse events based on the FDA adverse event reporting system database
    Zhang, Ya-Jun
    Duan, Dan-Dan
    Tian, Qian-Yu
    Wang, Cai-E.
    Wei, Shu-Xun
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [5] Assessment of the Relationship between Hypnotics and Delirium Using the Japanese Adverse Drug Event Report (JADER) Database
    Kikuchi, Norikazu
    Hazama, Katsuyuki
    Imai, Toru
    Suzuki, Shinichiro
    Yoshida, Yoshikazu
    Hidaka, Shinji
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (07): : 985 - 990
  • [6] A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data
    Wei, Chunyan
    Liu, Ying
    Jiang, Aidou
    Wu, Bin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 709 - 716
  • [7] A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data
    Chunyan Wei
    Ying Liu
    Aidou Jiang
    Bin Wu
    International Journal of Clinical Pharmacy, 2022, 44 : 709 - 716
  • [8] Delirium risk of histamine-2 receptor antagonists and proton pump inhibitors: A study based on the adverse drug event reporting database in Japan
    Kikkawa, Nao
    Sogawa, Rintaro
    Monji, Akira
    Sumi, Shintaro
    Murakawa-Hirachi, Toru
    Kubo, Toshiki
    Eguchi, Yuko
    Miyamoto, Yuki
    Kamo, Masahiro
    Tobita, Shuko
    Yukawa, Misako
    Uchida, Rina
    Egoshi, Masayoshi
    Shimanoe, Chisato
    GENERAL HOSPITAL PSYCHIATRY, 2021, 72 : 88 - 91
  • [9] The drug risks of cilostazol: A pharmacovigilance study of FDA Adverse Event Reporting System database
    Peng, Lufeng
    Li, Xueli
    Li, Junhai
    Liu, Shibin
    Liang, Gang
    PLOS ONE, 2024, 19 (12):
  • [10] Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
    Fang, Runan
    Zhou, Yang
    Han, Lu
    Chen, Wenjing
    Guan, Ning
    Li, Jianhong
    SCIENTIFIC REPORTS, 2024, 14 (01):